CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
In: Bone marrow transplantation (Basingstoke), Jg. 48 (2013), Heft 10, S. 1313-1316
Online
academicJournal
- print, 26 ref
Zugriff:
Preemptive therapy at CMV reactivation has diminished post-transplant CMV mortality. Furthermore, recent studies suggest a favorable 'virus-versus-leukemia' effect from reactivating CMV, reducing relapse of AML after SCT. We studied the relationship of CMV reactivation with leukemic relapse in 110 patients with CML receiving HLA-identical sibling SCT between 1993 and 2008. Of these, 79 (72%) were in chronic phase, 5 in second chronic phase, 17 in accelerated phase and 9 in blast phase. A total of 97 patients (88%) received a myeloablative conditioning regimen, 97 received 4-log ex vivo T cell-depleted grafts and 13 received T-replete grafts. CMV reactivation before day 100 was observed in 72 patients (65.5%). At a median follow-up of 6.2 years, CMV reactivation < day 100 as a time-dependent covariate was an independent factor associated with decreased relapse. We conclude that CMV reactivation may contribute to a beneficial GVL effect in CML transplant recipients.
Titel: |
CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML
|
---|---|
Autor/in / Beteiligte Person: | ITO, S ; POPHALI, P ; WU, C.O ; KOKLANARIS, E. K ; SUPERATA, J ; FAHLE, G. A ; CHILDS, R ; BATTIWALLA, M ; BARRETT, A. J |
Link: | |
Zeitschrift: | Bone marrow transplantation (Basingstoke), Jg. 48 (2013), Heft 10, S. 1313-1316 |
Veröffentlichung: | Basingstoke: Nature Publishing Group, 2013 |
Medientyp: | academicJournal |
Umfang: | print, 26 ref |
ISSN: | 0268-3369 (print) |
Schlagwort: |
|
Sonstiges: |
|